Pathological Changes and Expression of JAK-STAT Signaling Pathway Hallmark Proteins in Rat Retinas at Different Time Points After Retinal Ischemia Reperfusion Injury.


Journal

Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087

Informations de publication

Date de publication:
2022
Historique:
received: 21 02 2022
accepted: 30 03 2022
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Retinal ischemia reperfusion injury (RIRI) is a conventional pathological process in various retinal vascular diseases. Many studies select only one specific time point to apply drugs and then assess the therapeutic effect of drugs; however, the baselines are not the same at different time points, which may cause variation in the judgement. Therefore, further investigation is needed. Accordingly, this study aimed to investigate the pathological changes of retinal structure, expression of JAK-STAT signaling pathway hallmark proteins, and apoptosis at different time points after retinal ischemia reperfusion injury in rats. Sixty-six male SPF Sprague-Dawley rats were randomly divided into six groups: control group, RIRI 0, 6-, 24-, 72-, and 144-h groups. RIRI models were induced by perfusing equilibrium solution into the right eye anterior chamber to increase intraocular pressure to 110 mmHg for 60 min. Rats were sacrificed at different time points after reperfusion. Then hematoxylin-eosin staining, transmission electron microscope, immunohistochemistry, western blot, and TUNEL were used. Hematoxylin-eosin showed the pathological changes while transmission electron microscope revealed the ultra-structure changes of retina after RIRI. Immunohistochemistry showed that JAK2, STAT3, p-JAK2, p-STAT3, Bax, and Bcl-2 proteins mainly located in ganglion cell layer and inner nuclear layer, the relative expression of former five proteins had significant differences vs. control group (

Identifiants

pubmed: 35515015
doi: 10.3389/pore.2022.1610385
pii: 1610385
pmc: PMC9061953
doi:

Substances chimiques

STAT3 Transcription Factor 0
bcl-2-Associated X Protein 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Eosine Yellowish-(YS) TDQ283MPCW
Hematoxylin YKM8PY2Z55

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610385

Informations de copyright

Copyright © 2022 Wang, Yu, Han, Chen, Li, Ke, Cai, Ai and Xing.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurosurg Anesthesiol. 2017 Jan;29(1):37-45
pubmed: 27337676
Biochem Biophys Res Commun. 2018 Jan 22;495(4):2462-2468
pubmed: 29288664
Prog Retin Eye Res. 2004 Jan;23(1):91-147
pubmed: 14766318
Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59
pubmed: 18097445
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):965-977
pubmed: 30884523
Exp Eye Res. 2020 Dec;201:108281
pubmed: 33031790
Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):117-127
pubmed: 29942363
Cell Biol Int. 2019 Jun;43(6):582-592
pubmed: 30958602
Front Cell Dev Biol. 2021 May 14;9:669363
pubmed: 34055801
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2639-2645
pubmed: 30107910
Ann Transl Med. 2020 Apr;8(7):483
pubmed: 32395527
Ann Transl Med. 2021 May;9(10):859
pubmed: 34164493
Toxicol Pathol. 2021 Apr;49(3):521-527
pubmed: 33043844
Neurosci Lett. 2018 Jan 1;662:219-226
pubmed: 29061394
Hepat Oncol. 2020 Mar 18;7(1):HEP18
pubmed: 32273976
Cancers (Basel). 2019 Dec 12;11(12):
pubmed: 31842362
Nat Rev Neurol. 2013 Jan;9(1):44-53
pubmed: 23165340
Exp Neurol. 2021 Jul;341:113690
pubmed: 33798563
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1649-56
pubmed: 18708442
J Vis Exp. 2016 Jul 14;(113):
pubmed: 27501124
Eur Surg Res. 2021;62(3):144-150
pubmed: 33915540
Cell. 2020 Jun 25;181(7):1696-1696.e1
pubmed: 32589961
Ann Transl Med. 2021 Sep;9(18):1435
pubmed: 34733987
Int Immunopharmacol. 2020 Mar;80:106210
pubmed: 31972425
Endocrine. 2019 Apr;64(1):55-66
pubmed: 30830585
Mol Cell Biochem. 2011 May;351(1-2):41-58
pubmed: 21210296
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Front Immunol. 2016 Oct 24;7:444
pubmed: 27822213
Curr Med Chem. 2021;28(25):5137-5151
pubmed: 33290193
FEBS J. 2016 Aug;283(16):3002-15
pubmed: 26972840
Int J Mol Sci. 2016 Jan 15;17(1):
pubmed: 26784179

Auteurs

Shun Wang (S)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.
Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Aihua Yu (A)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.
Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Mengyao Han (M)

Retinal and Vitreous Diseases Department, Wuhan Aier Eye Hospital of Wuhan University, Wuhan, China.

Xiaomin Chen (X)

Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Zhi Li (Z)

Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Min Ke (M)

Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Xiaojun Cai (X)

Department of Ophthalmology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Ming Ai (M)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

Yiqiao Xing (Y)

Eye Center, Renmin Hospital of Wuhan University, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH